Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 11-20 of 34 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2013The genomic landscape of hypodiploid acute lymphoblastic leukemiaTo, L.
2018Tight junction protein claudin-2 promotes self-renewal of human colorectal cancer stem-like cellsPaquet-Fifield, S.; Koh, S.L.; Cheng, L.; Beyit, L.M.; Shembrey, C.; Mølck, C.; Behrenbruch, C.; Papin, M.; Gironella, M.; Guelfi, S.; Nasr, R.; Grillet, F.; Prudhomme, M.; Bourgaux, J.F.; Castells, A.; Pascussi, J.M.; Heriot, A.G.; Puisieux, A.; Davis, M.J.; Pannequin, J.; et al.
2019Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemiaBell, C.C.; Fennell, K.A.; Chan, Y.C.; Rambow, F.; Yeung, M.M.; Vassiliadis, D.; Lara, L.; Yeh, P.; Martelotto, L.G.; Rogiers, A.; Kremer, B.E.; Barbash, O.; Mohammad, H.P.; Johanson, T.M.; Burr, M.L.; Dhar, A.; Karpinich, N.; Tian, L.; Tyler, D.S.; MacPherson, L.; et al.
2013Next-Generation Sequence Analysis of Cancer Xenograft ModelsRossello, F.J.; Tothill, R.W.; Britt, K.; Marini, K.D.; Falzon, J.; Thomas, D.M.; Peacock, C.D.; Marchionni, L.; Li, J.; Bennett, S.; Tantoso, E.; Brown, T.; Chan, P.; Martelotto, L.G.; Watkins, D.N.; Coleman, W.B.
2018Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapyMarini, K.D.; Croucher, D.R.; McCloy, R.A.; Vaghjiani, V.; Gonzalez-Rajal, A.; Hastings, J.F.; Chin, V.; Szczepny, A.; Kostyrko, K.; Marquez, C.; Samantha, W.; Jayasekara, N.; Alamgeer, M.; Boolell, V.; Han, J.Z.R.; Waugh, T.; Lee, H.C.; Oakes, S.R.; Kumar, B.; Harrison, C.A.; et al.
2015Progesterone receptor modulates ERα action in breast cancerMohammed, H.; Russell, I.; Stark, R.; Rueda, O.; Hickey, T.; Tarulli, G.; Serandour, A.; Birrell, S.; Bruna, A.; Saadi, A.; Menon, S.; Hadfield, J.; Pugh, M.; Raj, G.; Brown, G.; D'Santos, C.; Robinson, J.; Silva, G.; Launchbury, R.; Perou, C.; et al.
2016GD2-specific CAR T cells undergo potent activation and deletion following antigen encounter but can be protected from activation-induced cell death by PD-1 blockadeGargett, T.; Yu, W.; Dotti, G.; Yvon, E.; Christo, S.; Hayball, J.; Lewis, I.; Brenner, M.; Brown, M.
2013Peptidomimetic targeting of critical androgen receptor-coregulator interactions in prostate cancerRavindranathan, P.; Lee, T.; Yang, L.; Centenera, M.; Butler, L.; Tilley, W.; Hsieh, J.; Ahn, J.; Raj, G.
2012The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinomaPerez-Mancera, P.; Rust, A.; van der Weyden, L.; Kristiansen, G.; Li, A.; Sarver, A.; Silverstein, K.; Grützmann, R.; Aust, D.; Rümmele, P.; Knösel, T.; Herd, C.; Stemple, D.; Kettleborough, R.; Brosnan, J.; Li, A.; Morgan, R.; Knight, S.; Yu, J.; Stegeman, S.; et al.
2012ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expressionAhn, Y.; Gibbons, D.; Chakravarti, D.; Creighton, C.; Rizvi, Z.; Adams, H.; Pertsemlidis, A.; Gregory, P.; Wright, J.; Goodall, G.; Flores, E.; Kurie, J.